Additionally, elevated expression levels of AC016550.2 (Fig. 4B), AC016737.1 (Fig. 4C), AC019080.5 (Fig. 4D), AC068790.7 (Fig. 4E), AL138756.1 (Fig. 4F), and TGFB2-AS1 (Fig. 4M) corresponded to worse outcomes of GC patients with statistical significance (P < .05). This evidence concerns the gene TGFB2 and gastric cancer.